Home
Latest
E-paper
Companies
Industry
Economy
Blueprint
Finance
Markets
Budget
India News
Politics
External Affairs Defence Security
World News
Opinion
Technology
Immigration
Specials
Partner Content
Sports
Cricket
Lifestyle
Entertainment
Social Viral
Health
BS Decoded
Books
Education
Newsletters
Web Stories
BS at 50
Multimedia
Sudoku
Crossword
BS Apps
Management
Indulgence
Premium
Explore Business Standard
BFSI Insight Summit
Events
About Us
BS Support
Popular Search
Intas launches immuno-booster add-on drug to standard Covid-19 treatment
The formulation is the active biological component of black cumin; it fortifies the immunity and ensures higher success in fighting infection, the company says
Intas is the dark horse of Indian pharma sector
Low profile Chudgar family's value creation strategy tilts the Teva-asset sale deal in its favour